You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hyperphosphatemia

Showing 1 - 25 of 336
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hyperphosphatemia Patients on Hemodialysis Trial in Tokyo (TS-172 10mg bid, TS-172 30mg bid, TS-172 60mg bid)

Not yet recruiting
  • Hyperphosphatemia Patients on Hemodialysis
  • TS-172 10mg bid
  • +4 more
  • Tokyo, Japan
    Taisho Pharmaceutical Co., Ltd selected site
Jan 23, 2023

Chronic Kidney Diseases, Hyperphosphatemia Trial in Chengdu (AP-306, Sevelamer Carbonate)

Recruiting
  • Chronic Kidney Diseases
  • Hyperphosphatemia
  • Chengdu, Sichuan, China
    Sichuan Provincial People's Hospital
Mar 9, 2023

Chronic Kidney Diseases, Hemodialysis Complication, Hyperphosphatemia Trial in Cairo (Cholestyramine Resin 4000 MG [Questran],

Enrolling by invitation
  • Chronic Kidney Diseases
  • +2 more
  • Cholestyramine Resin 4000 MG [Questran]
  • Calcium Carbonate 500 MG Oral Tablet
  • Cairo, Egypt
    Ain Shams university
Oct 10, 2022

Chronic Kidney Disease Requiring Chronic Dialysis, Hyperphosphatemia Trial in Lauderdale Lakes (Tenapanor)

Completed
  • Chronic Kidney Disease Requiring Chronic Dialysis
  • Hyperphosphatemia
  • Lauderdale Lakes, Florida
    South Florida Research Institute
Sep 28, 2022

av Fistula Patency Loss asCause of Fistula Failure and

Not yet recruiting
  • AV Fistula
  • doppler ultrasound
  • Assiut, Egypt
    Faculty of Medicine Assiut U
Oct 3, 2022

End-Stage Kidney Disease, Hyperphosphatemia Trial (multimedia education)

Not yet recruiting
  • End-Stage Kidney Disease
  • Hyperphosphatemia
  • multimedia education
  • (no location specified)
Jun 7, 2023

Dialysis Related Complication Trial in L'Hospitalet de Llobregat (mHealth App)

Recruiting
  • Dialysis Related Complication
  • mHealth App
  • L'Hospitalet de Llobregat, Barcelona, Spain
    Hospital Bellvitge
Aug 2, 2022

Hyperphosphatemia Trial in Suita (KHK7791)

Completed
  • Hyperphosphatemia
  • Suita, Osaka, Japan
    Inoue Hospital
Jan 7, 2022

Peritoneal Dialysis Complication, Hyperphosphatemia, Hypoalbuminemia Trial in Aurora (Sucroferric Oxyhydroxide Chewable Tablet)

Completed
Has Results
  • Peritoneal Dialysis Complication
  • +2 more
  • Sucroferric Oxyhydroxide Chewable Tablet
  • Aurora, Colorado
    University of Colorado Anschutz Medical Campus
Aug 9, 2022

Hyperphosphatemia Trial in Suita (KHK7791, Placebo)

Completed
  • Hyperphosphatemia
  • Suita, Osaka, Japan
    Inoue Hospital
Oct 26, 2021

Hyperphosphatemia Trial in China (VS-505, Sevelamer Carbonate)

Completed
  • Hyperphosphatemia
  • Beijing, Beijing, China
  • +22 more
Oct 17, 2022

Hyperphosphatemia Trial in Kanoya (KHK7791)

Active, not recruiting
  • Hyperphosphatemia
  • Kanoya, Kagoshima, Japan
    Medical Corporation Seijinkai Ikeda Hospital
Sep 7, 2021

Hyperphosphatemia Trial in Tsukuba (KHK7791, Placebo)

Completed
  • Hyperphosphatemia
  • Tsukuba, Ibaraki, Japan
    Kikuchi medical clinic
Sep 7, 2021

Improving Phosphate Control in Children With CKD

Not yet recruiting
  • Chronic Kidney Diseases
  • +4 more
  • Knowledge questionnaire
  • Focus groups
  • (no location specified)
Jun 30, 2022

Maintenance Hemodialysis, Hyperphosphatemia Trial in Shanghai (Phosphate-binder intervention, Phosphorus-restricted dietary

Completed
  • Maintenance Hemodialysis
  • Hyperphosphatemia
  • Phosphate-binder intervention
  • Phosphorus-restricted dietary intervention
  • Shanghai, Shanghai, China
  • +1 more
Aug 25, 2021

Chronic Kidney Disease(CKD), Hyperphosphatemia, Blood Pressure Trial in Copenhagen (Intervention group; NNRD group)

Active, not recruiting
  • Chronic Kidney Disease(CKD)
  • +2 more
  • Intervention group; NNRD group
  • Copenhagen, Denmark
    Rigshospitalet
Dec 15, 2021

Hyperphosphatemia, End Stage Renal Disease Trial in Houston (Tenapanor, Sevelamer Carbonate)

Completed
  • Hyperphosphatemia
  • End Stage Renal Disease
  • Houston, California
    Ardelyx Site #509
Jan 5, 2022

Hyperphosphatemia Trial in Changchun (Lanthanum Polystyrene Sulphonate Powder, Lanthanum Carbonate 500 MG, Placebo)

Recruiting
  • Hyperphosphatemia
  • Lanthanum Polystyrene Sulphonate Powder
  • +2 more
  • Changchun, Jilin, China
    The First Hospital of Jilin University
Jul 27, 2021

Hyperphosphatemia Trial in Los Angeles (Ferric Citrate)

Completed
Has Results
  • Hyperphosphatemia
  • Ferric Citrate
  • Los Angeles, California
    Kaiser Permanente Los Angeles Medical Center
Jan 3, 2022

Rate of Termination of Premixed Parenteral Nutrition in Surgical

Completed
  • Hyperphosphatemia
  • +3 more
  • Parenteral Nutrition (PN) Premixed Olimel N9E
  • Riyadh, Saudi Arabia
    King Faisal Specialist Hospital & Research Centre
Feb 2, 2022

Hyperphosphatemia Trial in China (Placebo, Sevelamer Carbonate (GZ419831))

Completed
Has Results
  • Hyperphosphatemia
  • Placebo
  • Sevelamer Carbonate (GZ419831)
  • Beijing, China
  • +37 more
Mar 15, 2022

Hyperphosphatemia, Anemia, Iron Deficiency, Renal Insufficiency Trial in United States (Ferric Citrate 1 gram Oral Tablet,

Completed
  • Hyperphosphatemia
  • +2 more
  • Ferric Citrate 1 gram Oral Tablet
  • Standard of care phosphate-lowering therapy
  • Anchorage, Alaska
  • +12 more
Nov 3, 2022

Renal Insufficiency, Chronic, Hyperphosphatemia, Bone Diseases, Metabolic Trial in Suita (Lanthanum carbonate, Calcium

Enrolling by invitation
  • Renal Insufficiency, Chronic
  • +2 more
  • Lanthanum carbonate
  • Calcium Carbonate
  • Suita, Osaka, Japan
    Osaka University Hospital
Feb 24, 2021

Hyperphosphatemia, End Stage Renal Disease on Dialysis Trial in Batu Caves, Petaling Jaya, Kuala Lumpur (Phosphate mobile app,

Completed
  • Hyperphosphatemia
  • End Stage Renal Disease on Dialysis
  • Phosphate mobile app
  • One-off dietary counselling with a phosphate booklet
  • Batu Caves, Selangor, Malaysia
  • +2 more
Mar 8, 2021

Chronic Kidney Disease Requiring Chronic Dialysis, Hyperphosphatemia Trial in Guangzhou (PA21, sevelamer carbonate)

Completed
  • Chronic Kidney Disease Requiring Chronic Dialysis
  • Hyperphosphatemia
  • PA21
  • sevelamer carbonate
  • Guangzhou, Guangdong, China
    Southern Medical University Nanfang Hospital
May 31, 2021